Drug Information

Drug General Information
Drug ID
D02UUK
Former ID
DNC013693
Drug Name
KAZINOL S
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529832]
Formula
C30H40O5
Canonical SMILES
CC(=CCC1=C(C(=C(C=C1CCCC2=CC(=C(C=C2O)O)C(C)(C)C=C)O)O)<br />CC3C(O3)(C)C)C
InChI
1S/C30H40O5/c1-8-29(4,5)23-14-20(24(31)17-25(23)32)11-9-10-19-15-26(33)28(34)22(16-27-30(6,7)35-27)21(19)13-12-18(2)3/h8,12,14-15,17,27,31-34H,1,9-11,13,16H2,2-7H3
InChIKey
YTBAFGRFSDPCBF-UHFFFAOYSA-N
PubChem Compound ID
44569902
Target and Pathway
Target(s) Tyrosine oxidase Target Info Inhibitor [529832]
BioCyc Pathway (S)-reticuline biosynthesis
Eumelanin biosynthesis
L-dopachrome biosynthesis
KEGG Pathway Tyrosine metabolism
Riboflavin metabolism
Metabolic pathways
Melanogenesis
PathWhiz Pathway Riboflavin Metabolism
Tyrosine Metabolism
WikiPathways Dopamine metabolism
References
Ref 529832Bioorg Med Chem. 2009 Jan 1;17(1):35-41. Epub 2008 Nov 18.Tyrosinase inhibitory effects of 1,3-diphenylpropanes from Broussonetia kazinoki.
Ref 529832Bioorg Med Chem. 2009 Jan 1;17(1):35-41. Epub 2008 Nov 18.Tyrosinase inhibitory effects of 1,3-diphenylpropanes from Broussonetia kazinoki.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.